n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with Glioblastoma in 1 studies
N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide: calmodulin antagonist; structure given in first source
N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide : A sulfonamide that is 5-chloronaphthalene-2-sulfonamide in which one of the hydrogens of the nitrogen atom is substituted by a 4-aminobutyl group.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xiong, DD | 1 |
Xu, WQ | 1 |
He, RQ | 1 |
Dang, YW | 1 |
Chen, G | 1 |
Luo, DZ | 1 |
1 other study available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Glioblastoma
Article | Year |
---|---|
In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
Topics: Androstadienes; Antineoplastic Agents; Brain Neoplasms; Computational Biology; Drug Discovery; Gefit | 2019 |